ObjectiveThe global rise in type 2 diabetes is associated with a concomitant increase in diabetic complications. Diabetic polyneuropathy is the most frequent type 2 diabetes complication and is associated with poor outcomes. The metabolic syndrome has emerged as a major risk factor for diabetic polyneuropathy; however, the metabolites associated with the metabolic syndrome that correlate with diabetic polyneuropathy are unknown.MethodsWe conducted a global metabolomics analysis on plasma samples from a subcohort of participants from the Danish arm of Anglo‐Danish‐Dutch study of Intensive Treatment of Diabetes in Primary Care (ADDITION‐Denmark) with and without diabetic polyneuropathy versus lean control participants.ResultsCompared to lean ...
Diabetic retinopathy (DR) is a major cause of blindness worldwide and may be non-proliferative (NPDR...
Aims: To clarify whether parasympathetic neuropathy in Type 2 diabetic patients is associated with f...
Aims: To clarify whether parasympathetic neuropathy in Type 2 diabetic patients is associated with f...
A number of metabolic conditions, including hypoglycemia, high blood pressure (HBP), dyslipidemia, n...
OBJECTIVE: To determine whether circulating metabolic intermediates are associated with inflammation...
OBJECTIVE Metabolic syndrome components may cumulatively increase the risk of diabetic polyneuropath...
Diabetic distal sensorimotor polyneuropathy (DSPN) is a frequent, disabling complication of diabetes...
Diabetic distal sensorimotor polyneuropathy (DSPN) is a frequent, disabling complication of diabetes...
Pathophysiology of diabetic kidney disease (DKD) is incompletely understood. We aim to elucidate met...
Aims/hypothesis: The aims of the present work were to identify plasma metabolites that predict futur...
Aims/hypothesis: The aims of the present work were to identify plasma metabolites that predict futur...
Diabetic polyneuropathy (DPN) encompasses multiple syndromes with a common pathogenesis. Glycemic co...
Background and purposeDiabetic distal sensorimotor polyneuropathy (DSPN) is a frequent, disabling co...
Aims/hypothesis: Metabolomics has opened new avenues for studying metabolic alterations in type 2 di...
Context: Type 2 diabetes mellitus (T2DM) is accompanied by an increased risk for coronary artery dis...
Diabetic retinopathy (DR) is a major cause of blindness worldwide and may be non-proliferative (NPDR...
Aims: To clarify whether parasympathetic neuropathy in Type 2 diabetic patients is associated with f...
Aims: To clarify whether parasympathetic neuropathy in Type 2 diabetic patients is associated with f...
A number of metabolic conditions, including hypoglycemia, high blood pressure (HBP), dyslipidemia, n...
OBJECTIVE: To determine whether circulating metabolic intermediates are associated with inflammation...
OBJECTIVE Metabolic syndrome components may cumulatively increase the risk of diabetic polyneuropath...
Diabetic distal sensorimotor polyneuropathy (DSPN) is a frequent, disabling complication of diabetes...
Diabetic distal sensorimotor polyneuropathy (DSPN) is a frequent, disabling complication of diabetes...
Pathophysiology of diabetic kidney disease (DKD) is incompletely understood. We aim to elucidate met...
Aims/hypothesis: The aims of the present work were to identify plasma metabolites that predict futur...
Aims/hypothesis: The aims of the present work were to identify plasma metabolites that predict futur...
Diabetic polyneuropathy (DPN) encompasses multiple syndromes with a common pathogenesis. Glycemic co...
Background and purposeDiabetic distal sensorimotor polyneuropathy (DSPN) is a frequent, disabling co...
Aims/hypothesis: Metabolomics has opened new avenues for studying metabolic alterations in type 2 di...
Context: Type 2 diabetes mellitus (T2DM) is accompanied by an increased risk for coronary artery dis...
Diabetic retinopathy (DR) is a major cause of blindness worldwide and may be non-proliferative (NPDR...
Aims: To clarify whether parasympathetic neuropathy in Type 2 diabetic patients is associated with f...
Aims: To clarify whether parasympathetic neuropathy in Type 2 diabetic patients is associated with f...